Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04886570
Other study ID # 2021-05-017BC
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date June 1, 2021
Est. completion date May 31, 2024

Study information

Verified date May 2021
Source Taipei Veterans General Hospital, Taiwan
Contact Chieh-Szu Yang
Phone (02) 2875-7557
Email jeffyang80@hotmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This longitudinal follow-up study aims to analyze how surgical and patient characteristics affect clinical outcomes in the subjects received total hip arthroplasty (THA) or hemiarthroplasty (HA).


Description:

Clinical assessments in this research include visual analogue scale (VAS), Harris Hip Score (HHS), Oxford Hip Score (OHS), forgotten joint score (FJS-12) and X-ray imaging applied to examine the stability of implants. Through analyzing surgical information, functional measures and self-reported questionnaires, this study intends to gain insights into the correlations between various clinical aspects.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 260
Est. completion date May 31, 2024
Est. primary completion date May 31, 2024
Accepts healthy volunteers
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: 1. 20 years old at least. 2. Osteoarthritis (OA) 3. Avascular necrosis 4. Rheumatoid arthritis (RA) 5. Previous failure of hemiarthroplasty 6. Femoral head or neck or trochanteric fractures 7. Developmental dysplasia of the hip Exclusion Criteria: 1. Being unable or unwilling to participate in 2. Subjects having cognitive impairment cannot fill out survey 3. Other complication causing severe deficiency in function and motion

Study Design


Related Conditions & MeSH terms


Intervention

Device:
hip arthroplasty
Hip arthroplasty is a kind of joint reconstruction surgery, which has been successfully utilized for treatment of osteoarthritis or hip fracture for decades. In this surgery, implants is applied to reconstruct hip joint, and usually comprised of four components, including femoral stem, femoral head, acetabular cup and liner.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Taipei Veterans General Hospital, Taiwan

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analogue Scale Visual Analogue Scale (VAS) is a patient-reported outcome measure. Scale from 0 to 10 stands for no pain to extreme pain. Pre-operation, 6 weeks, 12 weeks and 1 year after surgery
Primary Harris Hip Score Harris Hip Score (HHS) assesses the results of hip replacement. the domains cover pain, function, absence of deformity and range of motion. The maximum score of HHS is 100, and the higher score participants get, the less dysfunction they have. Pre-operation, 6 weeks, 12 weeks and 1 year after surgery
Primary Oxford Hip Score Oxford Hip Score (OHS) is a patient-reported outcome measure with 12 questions related to the condition of function and pain. Total scores is from 0 to 48, higher scores represent a better outcome. Pre-operation, 6 weeks, 12 weeks and 1 year after surgery
Primary Forgotten Joint Score (FJS-12) Forgotten Joint Score (FJS-12) is a patient-reported questionnaire with 12 questions, assessing the ability of the patient to forget the affected joints during daily activities. The higher the scores, the better the outcome. Pre-operation, 6 weeks, 12 weeks and 1 year after surgery
Primary Radiographic analysis X-ray imaging will be applied to examine the stability of implants, such as radiolucent line and loosening. The width of radiolucent line around implant suggest the possibility of implant loosening; generally, the wider the width is, the higher risk of loosening. Pre-operation, 6 weeks, 12 weeks and 1 year after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT05556759 - Anterior Iliopsoas Muscle Space Block Versus Supra-iliac Anterior Quadratus Lumborum Block in Total Hip Arthroplasty N/A
Withdrawn NCT05030688 - Fascia Iliaca Compartment Block and PENG Block for Hip Arthroplasty N/A
Not yet recruiting NCT05015517 - ESP Block vs FIB in Patients Undergoing Hip Arthroplasty N/A
Completed NCT05134207 - The Effect of Oral Carbohydrate Solution on Anxiety and Comfort in Patients Undergoing Hip Arthroplasty N/A
Recruiting NCT04438265 - Quadratus Lumborum Type 2 as Chronic Hip Pain Treatment
Recruiting NCT04229368 - Effect of Vitamin D Status and Repletion on Postoperative Total Joint Arthroplasty Complications N/A
Active, not recruiting NCT05142462 - Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup
Active, not recruiting NCT06083428 - Erector Spinae vs. PENG Block for Total Hip Arthroplasty Phase 4
Completed NCT05396924 - Rectal Temperature Measurement in Detecting Hypothermia During Hip Arthroscopy N/A
Active, not recruiting NCT05524363 - Assessment of Safety and Performances of HYPE SCS Stem Associated to NOVAE Sunfit TH Acetabular Cup in Hip Arthroplasty
Recruiting NCT06147401 - Comparison of PENG Associated With LFCN Block Versus FICB for Multimodal Analgesic Management in THA N/A
Completed NCT03977454 - Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty Phase 2
Recruiting NCT05397145 - Iliopsoas Plane Block vs PENG Block for Hip Arthroplasty N/A
Completed NCT03981354 - Nutritional Status and Its Modifications After Hip Replacement
Active, not recruiting NCT04995822 - Post Market Clinical Follow-up of EUROSTEM Femoral Stem
Completed NCT04883788 - The Impact of COVID-19 Pandemic on Hip and Knee Replacement
Not yet recruiting NCT06317870 - Pericapsular Nerve Block Versus Intrathecal Morphine for Analgesia After Primary Hip Arthroplasty N/A
Completed NCT03541798 - Comparison of Three Different Sitting Positions for Performing Combined Spinal-Epidural Anesthesia N/A
Completed NCT04306133 - PENG Block Combined to Wound Infiltration for Hip Replacement N/A
Completed NCT04123873 - Effect of Combinations of Paracetamol, Ibuprofen, and Dexamethasone on Patient-Controlled Morphine Consumption in the First 24 Hours After Total Hip Arthroplasty Phase 4